News & Analysis as of

International Harmonization Biosimilars

Goodwin

Brexit’s Impact on the Biosimilar Market

Goodwin on

The United Kingdom’s referendum in favor of withdrawal from the European Union, colloquially known as “Brexit,” has already sent shockwaves through the business world, both within the UK, and abroad. The impact of Brexit on...more

McGuireWoods LLP

International Council on Harmonisation (ICH) Includes International Generic and Biosimilars Trade Organization (IGBA) for the...

McGuireWoods LLP on

On June 15, 2016, the International Council for Harmonisation (ICH) (formerly the International Conference on Harmonisation) announced that the International Generic and Biosimilars Medicines Association (IGBA) could join ICH...more

McGuireWoods LLP

IGPA 2015 Focuses on Biosimilars, Quality, and Harmonization in Toronto-Part Two of Two

McGuireWoods LLP on

The following day features a panel of chief executive officers from a variety of pharmaceutical companies of different sizes and focus areas. Common themes included ongoing industry consolidation and increasing concern about...more

McGuireWoods LLP

IGPA 2015 Focuses on Biosimilars, Quality, and Harmonization in Toronto-Part One of Two

McGuireWoods LLP on

On September 16-18, 2015 the International Generic Pharmaceutical Alliance (IGPA) held its 18th Annual Meeting in Toronto, Canada. IGPA is composed of members: the Canadian Generic Pharmaceutical Association (CGPA-Canada),...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide